Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,486 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.
Cole CB, Morelli MP, Fantini M, Miettinen M, Fetsch P, Peer C, Figg WD, Yin T, Houston N, McCoy A, Lipkowitz S, Zimmer A, Lee JM, Pavelova M, Villanueva EN, Trewhitt K, Solarz BB, Fergusson M, Mavroukakis SA, Zaki A, Tsang KY, Arlen PM, Annunziata CM. Cole CB, et al. Among authors: yin t. J Exp Clin Cancer Res. 2023 Apr 26;42(1):102. doi: 10.1186/s13046-023-02668-3. J Exp Clin Cancer Res. 2023. PMID: 37101182 Free PMC article. No abstract available.
First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.
Cole CB, Morelli MP, Fantini M, Miettinen M, Fetsch P, Peer C, Figg WD, Yin T, Houston N, McCoy A, Lipkowitz S, Zimmer A, Lee JM, Pavelova M, Villanueva EN, Trewhitt K, Solarz BB, Fergusson M, Mavroukakis SA, Zaki A, Tsang KY, Arlen PM, Annunziata CM. Cole CB, et al. Among authors: yin t. J Exp Clin Cancer Res. 2023 Mar 29;42(1):76. doi: 10.1186/s13046-023-02649-6. J Exp Clin Cancer Res. 2023. PMID: 36991390 Free PMC article. Clinical Trial.
Development and validation of a simple, selective, and sensitive LC-MS/MS assay for the quantification of remdesivir in human plasma.
Nguyen R, Goodell JC, Shankarappa PS, Zimmerman S, Yin T, Peer CJ, Figg WD. Nguyen R, et al. Among authors: yin t. J Chromatogr B Analyt Technol Biomed Life Sci. 2021 May 1;1171:122641. doi: 10.1016/j.jchromb.2021.122641. Epub 2021 Mar 10. J Chromatogr B Analyt Technol Biomed Life Sci. 2021. PMID: 33756448 Free PMC article.
Quantitation of the next-generation imipridone ONC206 in human plasma by a simple and sensitive UPLC-MS/MS assay for clinical pharmacokinetic application.
Goodell JC, Zimmerman SM, Peer CJ, Prabhu V, Yin T, Richardson WJ, Azinfar A, Dunn JA, Mullin M, Theeler BJ, Gilbert M, Figg WD. Goodell JC, et al. Among authors: yin t. J Pharm Biomed Anal. 2022 May 10;213:114685. doi: 10.1016/j.jpba.2022.114685. Epub 2022 Feb 22. J Pharm Biomed Anal. 2022. PMID: 35219065 Free PMC article. Clinical Trial.
Association Between Exposure to Multiple Toxic Metals in Follicular Fluid and the Risk of PCOS Among Infertile Women: The Mediating Effect of Metabolic Markers.
Wang X, Zhang Y, Peng J, Zhang H, Jiang T, Zhang Z, Yin T, Su X, Zhang T, Shen L, He S, Wang X, Li D, Yue X, Ji D, Zhang D, Dong R, Zou W, Liang D, Liu Y, Du Y, Zhang Z, Cao Y, Liang C, Ji D. Wang X, et al. Among authors: yin t. Biol Trace Elem Res. 2024 May 24. doi: 10.1007/s12011-024-04236-y. Online ahead of print. Biol Trace Elem Res. 2024. PMID: 38789898
Multi-Interface Engineering of MXenes for Self-Powered Wearable Devices.
Liu C, Feng Z, Yin T, Wan T, Guan P, Li M, Hu L, Lin CH, Han Z, Xu H, Chen W, Wu T, Liu G, Zhou Y, Peng S, Wang C, Chu D. Liu C, et al. Among authors: yin t. Adv Mater. 2024 May 23:e2403791. doi: 10.1002/adma.202403791. Online ahead of print. Adv Mater. 2024. PMID: 38780429 Review.
2,486 results